Previous 10 | Next 10 |
Shares of DermTech (NASDAQ: DMTK) lost 19% of their value in July, according to data provided by S&P Global Intelligence . The stock opened at $41.24 when the market opened on July 1 but was down to $33.66 at the close on July 30. The stock's nadir in the month came on July ...
DermTech reported Q2 2021 earning recently, on August 4, 2021. In the quarter, Dermtech beat both internal and analyst revenue estimates, but they missed analyst earnings by $0.06. The major metrics that impressed from the quarter was the strong revenue growth, along with their in...
The following slide deck was published by DermTech, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: DermTech, Inc. 2021 Q2 - Results - Earnings Call Presentation
DermTech, Inc. (DMTK) Q2 2021 Earnings Conference Call August 04, 2021, 16:30 ET Company Participants Caroline Corner - IR John Dobak - President, CEO & Director Kevin Sun - CFO, Treasurer & Secretary Conference Call Participants Griffin Soriano - Blair Kyle Boucher - Cowen Kevin DeGe...
DermTech (NASDAQ:DMTK): Q2 GAAP EPS of -$0.59 misses by $0.06. Revenue of $3.12M (+271.4% Y/Y) beats by $0.27M. Management estimates that full year 2021 assay revenue will be between $11.5 million and $13.5 million Shares +5.2%. Press Release For further details see: DermTech EPS misses...
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported unaudited financial results for the quarter ended June 30, 2021. Second Quarter 2021 Highlights Billable sample volu...
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it plans to release its second quarter 2021 financial results after the market closes on Wednesday, August 4, 2021. In conjunctio...
DermTech (DMTK) announces the company has decided to set up a new corporate headquarters in San Diego.The 95,997 square-foot building, which DermTech lease out from Kilroy Realty, looks to further the company's expansion in the region.The first portion of the new building is slated ...
DermTech , Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced expansion plans to support the Company’s continued growth in San Diego, with the lease of a ...
Every year it seems like the cost of healthcare just goes up. Even as standards of care get better, it often comes with more cost to the patient. But every once in a while there's a disruptive technology that turns that equation on its head. DermTech (NASDAQ: DMTK) is one of those c...